Skip to main content
. 2023 Apr 17;15(4):1256. doi: 10.3390/pharmaceutics15041256

Figure 9.

Figure 9

Subgroup meta-analyses of the effect of 3 months supplementation with Lacticaseibacillus rhamnosus GG (LGG) compared to placebo on the SCORAD index change in children with AD aged under 1 year at treatment time [41,42].